Search research articles
Contact Us
Filters
Showing results (921-930 of 1,023) with videos related to
Page
of 103
Sort By:
European Heart Journal
|
October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
John H Alexander, Renato D Lopes, Laine Thomas, et al.
European Heart Journal
|
February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
M T Roe, K W Mahaffey, R Kilaru, et al.
Annals of Human Genetics
|
March 6, 2008
Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease
L Wang, E R Hauser, S H Shah, et al.
American Heart Journal
|
June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation
Saibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation. Heart Failure
|
April 12, 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial
John J V McMurray, Justin A Ezekowitz, Basil S Lewis, et al.
BMC Medical Genetics
|
April 24, 2008
Genetic and functional association of FAM5C with myocardial infarction
Jessica J Connelly, Svati H Shah, Jennifer F Doss, et al.
Journal of the American College of Cardiology
|
August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy
Andre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
American Heart Journal
|
September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Journal of the American Heart Association
|
June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Lars Wallentin, Claes Held, Paul W Armstrong, et al.
Journal of the American College of Cardiology
|
July 15, 2017
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial
Joseph G Rogers, Chetan B Patel, Robert J Mentz, et al.
Page
of 103
Search research articles
Search
Showing results (921-930 of 1,023) with videos related to
Sort By:
Page
of 103
European Heart Journal
|
October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
John H Alexander, Renato D Lopes, Laine Thomas, et al.
European Heart Journal
|
February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
M T Roe, K W Mahaffey, R Kilaru, et al.
Annals of Human Genetics
|
March 6, 2008
Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease
L Wang, E R Hauser, S H Shah, et al.
American Heart Journal
|
June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation
Saibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation. Heart Failure
|
April 12, 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial
John J V McMurray, Justin A Ezekowitz, Basil S Lewis, et al.
BMC Medical Genetics
|
April 24, 2008
Genetic and functional association of FAM5C with myocardial infarction
Jessica J Connelly, Svati H Shah, Jennifer F Doss, et al.
Journal of the American College of Cardiology
|
August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy
Andre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
American Heart Journal
|
September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Journal of the American Heart Association
|
June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Lars Wallentin, Claes Held, Paul W Armstrong, et al.
Journal of the American College of Cardiology
|
July 15, 2017
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial
Joseph G Rogers, Chetan B Patel, Robert J Mentz, et al.
Page
of 103